Xanthine Oxidase Pathway and Muscle Damage. Insights from McArdle Disease

Helios Pareja-Galeano, Alejandro Santos-Lozano, María Morán

  • 1Research Institute of Hospital 12 de Octubre (i+12), 6th Floor, Laboratories Sector, CAA Building, Avda. de Córdoba s/n, 28041 Madrid, Spain. fabian.sanchis@uv.es.

Insights

The xanthine oxidase (XO) pathway may contribute to skeletal muscle damage, particularly when muscle glycogen is low, as seen in McArdle disease. XO inhibitors show potential in reducing this damage.

Area of Science:

  • Biochemistry
  • Exercise Physiology
  • Muscle Metabolism

Background:

  • The xanthine oxidase (XO) pathway is implicated in cellular damage.
  • Skeletal muscle damage can occur due to various factors, including metabolic disturbances.
  • McArdle disease presents a unique model of impaired muscle glycogenolysis.

Purpose of the Study:

  • To review the role of the xanthine oxidase pathway in skeletal muscle damage.
  • To explore the connection between XO, purine metabolism, and muscle injury under glycogen-depleted conditions.
  • To present preliminary data on XO's involvement in McArdle disease-related muscle damage.

Main Methods:

  • Literature review on xanthine oxidase and muscle damage.
  • Hypothesis formulation regarding purine nucleotide cycle and glycogen availability.
  • Presentation of preliminary laboratory data.

Main Results:

  • Xanthine oxidase inhibitors like allopurinol may attenuate muscle damage.
  • Impaired muscle glycogen availability may increase reliance on the XO pathway.
  • Preliminary data suggest a potential role for XO in McArdle disease muscle damage.

Conclusions:

  • The xanthine oxidase pathway is a potential contributor to skeletal muscle damage.
  • Further research is warranted to elucidate the precise mechanisms and therapeutic potential of targeting XO in muscle injury, especially in metabolic myopathies.

Related Concept Videos

Muscle Recovery and Fatigue01:24

Muscle Recovery and Fatigue

Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
4.8K
Electron Transport Chain: Complex III and IV01:43

Electron Transport Chain: Complex III and IV

During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
9.7K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
560
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.5K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.5K